NFE2L2 and major depressive disorder: This prediction is consistent with observations in MDD patients that both the nuclear translocation of NRF2 and the NRF2-mediated gene transcriptions are diminished [84], whereas biomarkers reflecting oxidative damage are elevated [85,86].